REGENXBIO Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
REGENXBIO (RGNX) IPO Opens Up 38%
September 17, 2015 11:06 AM EDTToday's IPO for REGENXBIO Inc. (NASDAQ: RGNX) opened for trading at $30.26 after pricing 6,300,000 shares of its common stock at a public offering price of $22.00 per share, inline with the expected pricing. The number of shares offered was raised from 5,555,555 shares.
In addition, REGENXBIO granted the underwriters a 30-day option... More
REGENXBIO (RGNX) IPO Prices In-Line at $22
September 17, 2015 7:32 AM EDTREGENXBIO Inc. (NASDAQ: RGNX) announced the pricing of its initial public offering of 6,300,000 shares of its common stock at a public offering price of $22.00 per share, inline with the expected pricing. The number of shares offered was raised from... More
